{"id":20025,"date":"2022-07-28T10:22:27","date_gmt":"2022-07-28T14:22:27","guid":{"rendered":"https:\/\/medicarereport.org\/?p=20025"},"modified":"2022-07-28T10:22:29","modified_gmt":"2022-07-28T14:22:29","slug":"everything-you-need-to-know-about-paxlovid-especially-should-you-take-it","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=20025","title":{"rendered":"Everything You Need to Know About Paxlovid \u2014 Especially, Should You Take It?"},"content":{"rendered":"\n

(By Michelle Andrews for Kaiser Health News)<\/p>\n\n\n\n

When President Joe Biden tested positive for covid-19 on July 21, his physician recommended he take the antiviral drug Paxlovid. The drug significantly reduces the likelihood of hospitalization or death for someone at high risk of developing severe covid. Biden started the five-day course that day, according to the White House, and within six days he tested negative for the virus and was cleared to leave isolation.<\/p>\n\n\n\n

Biden\u2019s chief medical adviser, Dr. Anthony Fauci, also took Paxlovid when he contracted covid in June yet soon tested positive for the disease again. So he took a second round of the drug even though it isn\u2019t approved for that. Continue reading here…<\/a><\/p>\n\n\n\n

Kaiser Health News is a nonprofit national health policy news service that is part of the nonpartisan Henry J. Kaiser Family Foundation.<\/p>\n\n\n\n

\"\"<\/p>\n\n\n\n

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/p>\n","protected":false},"excerpt":{"rendered":"

(By Michelle Andrews for Kaiser Health News) When President Joe Biden tested positive for covid-19 on July 21, his physician<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[52,15],"tags":[],"class_list":["post-20025","post","type-post","status-publish","format-standard","hentry","category-pandemic","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/20025","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=20025"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/20025\/revisions"}],"predecessor-version":[{"id":20026,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/20025\/revisions\/20026"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=20025"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=20025"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=20025"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}